what are the International Commission on the Clinical use of Heritble Human Genome Editing proposed set of strict preclinical and clinical criteria that would need to be fulfilled before considering heritable human genome editing as safe and effective.

Answer 1

1. Justification for heritable human genome editing: There must be a clear and compelling rationale for using heritable human genome editing, such as preventing a serious genetic disease or improving the health of future generations.

2. Scientific and technical feasibility: The proposed genome editing technology must be scientifically and technically feasible, with evidence of successful editing in relevant preclinical models.

3. Safety and efficacy: There must be robust preclinical data demonstrating the safety and efficacy of the genome editing approach, including evidence of off-target effects, unintended consequences, and long-term outcomes.

4. Informed consent: Informed consent must be obtained from all individuals involved in the process, including the parents, donors, and resulting offspring.

5. Ethical and legal considerations: The proposed genome editing must adhere to ethical and legal guidelines, including respect for human dignity, transparency, accountability, and adherence to international regulations.

6. Monitoring and follow-up: There must be a plan in place for monitoring and following up on individuals who have undergone heritable human genome editing, including long-term health monitoring and assessment of any potential risks or complications.

These criteria are designed to ensure that heritable human genome editing is only considered when it is safe, effective, and ethically sound. They aim to provide a framework for evaluating and regulating the use of this technology in a responsible and transparent manner.